Alnylam Pharmaceuticals
ALNY
#572
Rank
S$52.80 B
Marketcap
S$398.16
Share price
-1.18%
Change (1 day)
18.17%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company